Ileal Pouch–Anal Anastomosis (IPAA)

First procedure page in the wiki. Content below is from a textbook reference chapter (Sabiston Ch52 - Inflammatory Bowel Disease), not primary literature. Used primarily for Ulcerative Colitis not responding to medical therapy (or requiring colectomy for dysplasia), and increasingly for Crohn Disease in carefully selected patients without perianal disease.

Overview

Described in the mid-to-late 1970s. Two essential components: proctocolectomy, and creation of a small-bowel reservoir from the terminal ileum, which is then joined to the anal canal or lower rectum. Removes the entire colon and the majority of the rectum, along with the majority of at-risk mucosa (the extent depending on stapled vs. hand-sewn technique — see below).

Several pouch configurations have been described historically (S-pouch, W-pouch, H-pouch), but the J-pouch — simplest and easiest to construct, with the fewest complications — has become the standard, having “withstood the test of time.”

Construction

• J-pouch created using 15-cm limbs of terminal ileum and two firings of a linear GIA stapler: the stapler joins two limbs of intestine with staples while dividing the intervening wall, creating a reservoir roughly twice the diameter of the original ileum.
• The apex of the J-pouch is then joined to the distal rectum/anal canal in one of two ways:
  • Stapled anastomosis — using a circular stapler (typically 29 mm), leaving a short rectal cuff. Currently preferred: superior continence and much faster to perform. A common technical error is leaving too long a segment of retained rectal mucosa, which can cause persistent symptoms from retained IBD-affected mucosa (“cuffitis”).
  • Hand-sewn anastomosis — after a 2-cm mucosectomy of the distal rectum. Reserved for cases of dysplasia or cancer, where removing essentially all at-risk mucosa matters more than the faster/higher-continence stapled approach.
• Achieving tension-free reach: the apex of the J-pouch should reach just below the symphysis pubis without traction. Technical maneuvers to gain length:
  • Mobilize the small bowel mesentery up to the level of the pancreas.
  • “Peritoneal windowing” — the mesenteric peritoneum is lifted away from the SMA with a hemostat and divided with electrocautery, perpendicular to the axis of the SMA; each division site gains roughly an additional 1 cm of mesenteric length.
  • If tension remains, the more-tensioned of the superior mesenteric vessel or the ileocolic vessel (whichever is under greater tension when the pouch is put on distal traction) can be divided to gain further length on the small bowel mesentery.
  • Obesity, tall stature, and a long torso all make achieving tension-free reach more difficult.

Fecal diversion

IPAA is commonly performed with a temporary loop ileostomy for 2–3 months, during which immunosuppressant medications are weaned and the patient’s nutritional state recovers. This can typically be closed without a laparotomy.

In patients who are not on immunosuppression and are in good nutritional state (typically patients undergoing surgery for dysplasia rather than active colitis), the operation can safely be done in one stage, without diversion, provided the anastomosis is tension-free.

Complications

• Early: complications related to non-healing of the IPAA — pelvic sepsis, IPAA-anal anastomotic fistulas, IPAA-vaginal fistulas, IPAA-anal anastomotic sinuses, and IPAA-anal anastomotic strictures (often a reflection of anastomotic tension).
• Late: a subsequent diagnosis of Crohn’s disease (more common in patients who underwent emergent colectomy, and in those with an initial diagnosis of indeterminate colitis) — a meaningful “gotcha,” since IPAA outcomes and appropriateness differ for Crohn’s vs. UC.

Functional outcomes

With a “good” result, patients have up to 6 bowel movements per 24 hours, usually including one nocturnal movement. By around 6 months postoperatively, the ileal pouch has typically enlarged significantly, allowing most patients to reduce antidiarrheal medication use.

Open items / gaps

• No primary trial or cohort data yet on IPAA functional/complication outcomes — all figures above are the textbook’s summary, not sourced to a specific study.
• Pouchitis (a common long-term IPAA complication, and more likely in patients with sclerosing cholangitis per Inflammatory Bowel Disease) is not covered in this chapter chunk at all — worth a dedicated source.
• Cuffitis is mentioned only in passing (as a consequence of a technical error) — not developed as its own topic.